Unity Biotechnology (NASDAQ:UBX – Get Rating) and Bolt Biotherapeutics (NASDAQ:BOLT – Get Rating) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, profitability, valuation, risk, dividends and analyst recommendations. Insider & Institutional Ownership 24.2% of Unity Biotechnology shares […]